Triasima Portfolio Management inc.

Position in LLY — ELI LILLY & Co

CIK 1938757 MONTREAL, A8

Position in LLY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$12,049,474

+$6,208,015 QoQ

Shares Held

10,046

+58.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.64%

of 13F equity value

Holder Rank

#1,152

of 4,605 holders

Holding Since

Dec 2020

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Triasima Portfolio Management inc. holds $24,778,845 across 3 Drug Manufacturers - General names. LLY ranks #1 (48.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	10,046	$12,049,474
2	NVS	Novartis AG	44,755	$7,014,003
3	GILD	Gilead Sciences, Inc.	45,238	$5,715,368

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,049,474	10,046	+58.2%	Shares	Sole	2026-07-21
2026-03-31	$5,841,459	6,351	+6.4%	Shares	Sole	2026-04-24
2025-12-31	$6,415,840	5,970	+12.4%	Shares	Sole	2026-02-02
2024-12-31	$4,100,092	5,311	-46.4%	Shares	Sole	2025-01-28
2024-06-30	$8,975,937	9,914	-0.3%	Shares	Sole	2024-08-06
2024-03-31	$7,736,812	9,945	-24.2%	Shares	Sole	2024-04-26
2023-12-31	$7,651,990	13,127	-9.3%	Shares	Sole	2024-01-29
2023-09-30	$7,772,808	14,471	-4.9%	Shares	Sole	2023-11-14
2023-06-30	$7,135,999	15,216	-3.2%	Shares	Sole	2023-08-08
2023-03-31	$5,395,815	15,712	-52.2%	Shares	Sole	2023-04-28
2022-12-31	$12,020,404	32,857	+48.9%	Shares	Sole	2023-02-21
2022-09-30	$7,133,747	22,062	-0.9%	Shares	Sole	2023-03-10
2022-06-30	$7,221,250	22,272	+13.6%	Shares	Sole	2023-03-10
2022-03-31	$5,616,288	19,612	+3.0%	Shares	Sole	2023-03-10
2021-12-31	$5,257,847	19,035	+9.0%	Shares	Sole	2023-03-10
2021-09-30	$4,034,133	17,460	+37.5%	Shares	Sole	2023-03-10
2021-06-30	$2,914,904	12,700	+53.4%	Shares	Sole	2023-03-10
2021-03-31	$1,546,869	8,280	0.0%	Shares	Sole	2023-03-10
2020-12-31	$1,397,995	8,280	—	Shares	Sole	2023-03-10
No filing history on record for this holder in this stock.